Analysts have mixed opinions on Chemours' future prospects, with bullish, somewhat bullish, and indifferent ratings.

In the last three months, 7 analysts have evaluated Chemours (NYSE:CC) with varying opinions from bullish to bearish. Recent assessments show a mix of sentiments, with 2 total bullish ratings, 2 total somewhat bullish ratings, and 3 total indifferent ratings. Analysts have established a 12-month average price target of $15.71, with a high estimate of $22.00 and a low estimate of $13.00, indicating a decline from the prior average price target. Analysts have taken various actions, such as raising, lowering, or maintaining ratings, offering insights into Chemours’ current state and future prospects.

Chemours, a provider of chemicals, operates in the Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials segments, generating revenue primarily from North America. The company exhibits strong market capitalization, positive revenue growth of 0.44% over the past 3 months, and a net margin exceeding industry standards. However, its return on equity and return on assets fall below industry averages, and the debt-to-equity ratio is higher than the industry average. Analyst ratings provide valuable insights into stocks and sectors, but users should consider the human perspective and potential variability in these ratings.

Read more at Nasdaq: Analyst Expectations For Chemours’s Future